| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Ankit Kedarmal Bankda CEO | XNSE Exchange | INE312C01025 ISIN |
| IN Country | 744 Employees | - Last Dividend | - Last Split | - IPO Date |
Syncom Formulations (India) Limited is a prominent entity in the pharmaceutical industry of India, engaged in the manufacturing, marketing, and distribution of a diverse range of pharmaceutical formulation products. The company operates through multiple segments, including Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties. Established in 1988 and based in Indore, India, Syncom Formulations also extends its product reach beyond domestic markets, exporting its pharmaceutical formulations to other countries. The company's operations are not limited to pharmaceuticals alone; it also ventures into the trading of commodities and property rentals, showcasing a wide-ranging business portfolio.
Syncom Formulations (India) Limited offers an exhaustive portfolio of pharmaceutical products across various therapeutic categories. These include antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, dermatology, gastroenterology, gynecology, ophthalmology, orthopedics, and pediatrics formulations. The formulations are available in diverse dosage forms, such as tablets, capsules, liquid orals, liquid vials, ampoule injections, dry vial injections, dry syrups, ointments, inhalers, and herbal products, ensuring a comprehensive healthcare solution.
The company's product range also encompasses specialized health solutions addressing specific medical conditions. These include an anemia tablet and syrup, lycopene, minerals, and vitamins capsules, products targeting the eradication of vaginal pathogens, capsules for menopause treatment, herbal uterine tonic, syrup for lactation insufficiency, cough suppressants, liver tonic, medicine for burning urination, and nutritional supplements. This array of products underscores Syncom Formulations' commitment to catering to the wide-ranging healthcare needs of its customers.
Beyond pharmaceuticals, Syncom Formulations engages in the trading of commodities, showcasing its versatility in business operations. This segment enables the company to diversify its revenue streams and leverage market opportunities in the trading sector.
The company also extends its business operations to the real estate sector through the renting of properties. This not only showcases the breadth of Syncom Formulations' business interests but also contributes to its revenue through property leases.